Immunic AG | WebDisclosure

Basculer en Français

8556	Companies
136171	Keywords
72490	Articles
72705	Press releases

Home
Companies
Immunic AG

BRIEF

published on 03/03/2025 at 12:35, 10 days 11 hours ago

Immunic participera aux conférences de mars pour présenter ses recherches

Biotechnologie Conférences Relations Avec Les Investisseurs Recherche Antivirale Virologie
BRIEF

published on 03/03/2025 at 12:35, 10 days 11 hours ago

Immunic to Join March Conferences to Present Research

Biotechnology Investor Relations Conférences Antiviral Research Virology
PRESS RELEASE

published on 03/03/2025 at 12:30, 10 days 11 hours ago

Immunic to Participate in Scientific and Investor Conferences in March
Immunic to participate in scientific and investor conferences in March including the 34th Annual Meeting of the Society for Virology in Hamburg, Germany, and Leerink Partners Global Healthcare Conference in Miami

Biotechnology Investor Conferences Clinical Pipeline Immunic Scientific Conferences
BRIEF

published on 02/26/2025 at 12:35, 15 days 11 hours ago

Immunic partage des données prometteuses sur le vidofludimus calcique au Forum ACTRIMS 2025

Sclérose En Plaques Neuroprotection Vidofludimus Calcique Activation De Nurr1 Essai CALLIPER
BRIEF

published on 02/26/2025 at 12:35, 15 days 11 hours ago

Immunic Shares Promising Data on Vidofludimus Calcium at ACTRIMS Forum 2025

Multiple Sclerosis Vidofludimus Calcium Neuroprotection Nurr1 Activation CALLIPER Trial
PRESS RELEASE

published on 02/26/2025 at 12:30, 15 days 11 hours ago

Immunic Presents Key Vidofludimus Calcium Data at the ACTRIMS Forum 2025, Highlighting Its Potential in Multiple Sclerosis
Immunic presents key data on vidofludimus calcium at ACTRIMS Forum 2025, highlighting its potential in multiple sclerosis. Phase 2 CALLIPER trial results expected in April

Clinical Trial Multiple Sclerosis Immunic Vidofludimus Calcium ACTRIMS Forum 2025
BRIEF

published on 02/20/2025 at 13:35, 21 days 10 hours ago

L'IMU-856 d'Immunic s'avère prometteur pour les patients atteints de la maladie cœliaque

Essai Clinique GLP-1 IMU-856 Maladie Cœliaque Gestion Du Poids
BRIEF

published on 02/20/2025 at 13:35, 21 days 10 hours ago

Immunic's IMU-856 Shows Promise in Celiac Disease Patients

Clinical Trial GLP-1 IMU-856 Celiac Disease Weight Management
PRESS RELEASE

published on 02/20/2025 at 13:30, 21 days 10 hours ago

Immunic’s Oral IMU-856 Demonstrated Dose-Dependent Increase of GLP-1 in Celiac Disease Patients and Corresponding Effects in Preclinical Testing
Immunic's Oral IMU-856 shows dose-dependent increase of GLP-1 in celiac disease patients, potential as oral weight management treatment. New data presented in webcast

Immunic GLP-1 IMU-856 Celiac Disease Weight Management
BRIEF

published on 02/04/2025 at 12:35, 1 month 9 days ago

Immunic Announces February Participation in Key Conferences

Biotechnology Investor Engagement Immunic Conferences IMU-856 Data IMU-838 Research

1 2 ... 8

Accesswire

Published on 03/13/2025 at 21:30, 2 hours 33 minutes ago

Star Royalties Highlights Copperstone Project Economics and Stream Valuation
Published on 03/13/2025 at 21:30, 2 hours 33 minutes ago

Relevant Gold Closes Second Tranche of Upsized $8.5 Million Non-Brokered Private Placement Led by Strategic Investors Kinross and Bollinger
Published on 03/13/2025 at 21:28, 2 hours 35 minutes ago

Zomedica Reports Record Revenue of $7.9 Million for the Fourth Quarter and $27.3 Million for the Full Year 2024; 70% Gross Margin, and $71 Million in Liquidity to Support Growth
Published on 03/13/2025 at 21:20, 2 hours 43 minutes ago

Fresh Vine Wine, Inc. To Change Corporate Name To Amaze Holdings, Inc. and Ticker Symbol to AMZE Following Strategic Acquisition
Published on 03/13/2025 at 21:15, 2 hours 48 minutes ago

Kingstone Reports Record Fourth Quarter and Full Year 2024 Results

View all ACCESSWIRE

EQS Group

Published on 03/13/2025 at 20:58, 3 hours 4 minutes ago

EQS-Adhoc: Deutsche Konsum REIT-AG: Deutsche Konsum REIT concludes bridge financing agreement. Changes in the Supervisory Board.
Published on 03/13/2025 at 19:49, 4 hours 14 minutes ago

EQS-Adhoc: ABO Energy GmbH & Co. KGaA increases forecast
Published on 03/13/2025 at 18:30, 5 hours 33 minutes ago

Swiss Prime Site: Annual General Meeting approves all proposals of the Board of Directors with a large majority
Published on 03/13/2025 at 17:55, 6 hours 8 minutes ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 03/13/2025 at 17:45, 6 hours 18 minutes ago

FIGEAC AÉRO: FIGEAC AÉRO INVESTS IN THE INDUSTRY OF THE FUTURE WITH THE SUPPORT OF FRANCE 2030 AND THE DGAC

Les Echos

Published on 03/13/2025 at 19:30, 4 hours 33 minutes ago

CDA - Sharholder Meeting report - March 13
Published on 03/13/2025 at 19:27, 4 hours 36 minutes ago

CDA - Compte rendu du l'AG et du Conseil du 13 mars
Published on 03/13/2025 at 18:00, 6 hours 3 minutes ago

Air Liquide has successfully issued a 500 million euros green bond to finance the energy transition
Published on 03/13/2025 at 18:00, 6 hours 3 minutes ago

Air Liquide a réalisé avec succès une émission obligataire verte de 500 millions d’euros
Published on 03/13/2025 at 17:45, 6 hours 18 minutes ago

Communiqué Conseil d'administration 13.03.2025

View all LES ECHOS COMFI WIRE